Position in TNYA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$99,855
+$28,086 QoQ
Shares Held
144,300
+43.2% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TNYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Corient Private Wealth LLC holds $250,401,460 across 107 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
112,098 | $55,682,439 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
196,791 | $15,603,558 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
187,447 | $14,671,476 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
32,580 | $12,109,008 | |
| 5 | TECH |
BIO-TECHNE Corp
|
122,377 | $8,645,935 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
13,758 | $8,578,663 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
23,797 | $7,163,610 | |
| 8 | CLDX |
Celldex Therapeutics, Inc.
|
186,110 | $6,925,153 |
All Filings in TNYA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $99,855 | 144,300 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $71,769 | 100,800 | Shares | Sole | 2026-03-09 | |
| 2023-03-31 | $36,346 | 12,753 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||